Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Vienna Institute For Research In Ocular Surgery

Clinical trials sponsored by Vienna Institute For Research In Ocular Surgery, explained in plain language.

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2 Completed 2 Terminated 1
Sort by
  • Can a stronger eylea dose cut eye injections in half?

    Disease control Ongoing

    This study tests whether switching wet AMD patients who don't respond well to the standard 2mg dose of aflibercept (Eylea) to a higher 8mg dose can extend the time between injections while keeping vision stable. Fifty adults who have already had at least four 2mg injections will …

    Sponsor: Vienna Institute for Research in Ocular Surgery • Aim: Disease control

    Last updated Jun 27, 2026 09:06 UTC

  • Could a common diabetes drug slow cataracts?

    Knowledge-focused Ongoing

    This pilot study looks at whether metformin, a standard diabetes medicine, gets into the lens capsule of the eye and can slow the growth of lens cells that cause cataracts. Researchers will collect blood and lens tissue from 40 people with type 2 diabetes and age-related cataract…

    Phase: NA • Sponsor: Vienna Institute for Research in Ocular Surgery • Aim: Knowledge-focused

    Last updated Jun 26, 2026 17:29 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space